Scott H. Gillis
Nessuna posizione attualmente
Profilo
Scott H.
Gillis served as President & Chief Executive Officer at NUCRYST Pharmaceuticals Corp.
from 1999 to 2007.
He also served as President & Director at Pericor Science, Inc. Additionally, he holds an MBA from Xavier University and an undergraduate degree from Salem State University.
Precedenti posizioni note di Scott H. Gillis
| Società | Posizione | Fine |
|---|---|---|
NUCRYST Pharmaceuticals Corp.
 NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Presidente | 22/08/2007 |
Pericor Science, Inc.
 Pericor Science, Inc. Pharmaceuticals: MajorHealth Technology Pericor Science, Inc. develops novel therapeutic products. It manufactures renal cell therapy devices. The company was founded by Howard Green and Philippe Djian in 1999 and is headquartered in Waltham, MA. | Presidente | - |
Formazione di Scott H. Gillis
| Xavier University | Masters Business Admin |
| Salem State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
NUCRYST Pharmaceuticals Corp.
NUCRYST Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activities is to develop, manufacture and commercialize innovative medical products that fight infection and inflammation. | Health Technology |
Pericor Science, Inc.
Pericor Science, Inc. Pharmaceuticals: MajorHealth Technology Pericor Science, Inc. develops novel therapeutic products. It manufactures renal cell therapy devices. The company was founded by Howard Green and Philippe Djian in 1999 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Scott H. Gillis
